Companies will work to discover inhibitors for target.
Argenta Discovery added a second two-year drug discovery project to its deal with Genentech. Scientists from the two companies will exploit Argenta’s expertise in computer-aided drug design, medicinal chemistry, and biology to discover new chemical entities acting against a second undisclosed drug target defined by Genentech.
The agreement provides options to further expand the relationship, including opportunities to pursue additional discovery projects.
